ELISA Analyzers Market (By Type: Optical Filter Elisa Analyzer, Optical Grating ELISA Analyzers; By Mode; By Application; By End-user) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The global ELISA analyzers market was valued at USD 667.58 million in 2022 and it is predicted to surpass around USD 871.38 million by 2032 with a CAGR of 2.7% from 2023 to 2032.

ELISA Analyzers Market Size 2023 to 2032

ELISA (Enzyme-Linked Immunosorbent Assay) is a widely used diagnostic tool that allows for the detection and measurement of specific proteins and antibodies in a sample. ELISA analyzers, which are automated instruments that perform various steps of the assay, provide accurate and reproducible results. These machines are valuable in the diagnosis of diseases such as HIV, hepatitis, and cancer, as well as in research fields like immunology and drug development. ELISA analyzers come in different types, including benchtop and microplate readers, and can be customized to suit specific requirements. With the advancement in technology, ELISA assays can now be performed in portable devices, making them more accessible to people in remote and underserved areas. In May 2022, Molecular Devices, LLC has launched automated work cells for ELISA workflows, which streamline and automate the process of ELISA testing, allowing for faster and more efficient analysis of large volumes of samples.

Report Scope of the ELISA Analyzers Market

Report Coverage Details
Market Size in 2022 USD 667.58 million
Revenue Forecast by 2032 USD 871.38 million
Growth rate from 2023 to 2032 CAGR of 2.7%
Base Year 2022
Forecast Period 2023 to 2032
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc.

 

The ELISA analyzer market is driven by the need for advancements in technology and automation in the medical diagnostics industry. A key example of this is the strategic merger of Gold Standard Diagnostics Inc. with Novatec Immundiagnostica GmbH and Virotech Diagnostics GmbH in May 2022, which has expanded the company's product portfolio to include automated ELISA analyzers. ELISA is a widely used diagnostic tool that can detect and measure specific proteins and antibodies in a sample, making it a valuable tool in the diagnosis of diseases such as HIV, hepatitis, and cancer as well as in research fields such as immunology and drug development. Automated ELISA analyzers are designed to provide accurate and reproducible results, further increasing the demand for these devices.

The market is segmented based on type, type of operations, application, end user, and region. The type segment includes optical filter ELISA analyzer and optical grating ELISA analyzers. The mode segment is segmented into automated ELISA analyzers and semi-automated analyzers. Application segment is further segmented into immunology, vaccine development, drug monitoring, and others. The end-user segment is classified into pharmaceutical and biotechnology companies, contract research organization, and diagnostic laboratories.

The ELISA (Enzyme-linked immunosorbent assay) analyzer market is growing rapidly across various regions, with North America and Europe leading the way in terms of market share. In North America, the U.S. and Canada are key players in the market, driven by the presence of a large number of research centers and pharmaceutical companies in the region. Europe, particularly the UK, Germany, France, Italy, Spain, Denmark, Sweden, and Norway, also have a strong ELISA analyzer market, due to the large number of research institutions and government funding for research in these countries. Asia Pacific, specifically Japan, China, India, Australia, Thailand, and South Korea, is also witnessing significant growth in the ELISA analyzer market, driven by increasing investments in research and development and rising prevalence of chronic diseases. Latin America, with Brazil, Mexico, and Argentina as major market players, also presents a significant growth opportunity in ELISA analyzer market. 

ELISA Analyzers Market Segmentations:

By type By Mode By Application By End-user

Optical Filter Elisa Analyzer

Optical Grating ELISA Analyzers

Automated ELISA Analyzers

Semi-Automated Analyzers

Immunology

Vaccine development

Drug Monitoring

Others

Biotechnology Companies

Pharmaceutical Companies

Contract Research Organization

Diagnostic Laboratories

Frequently Asked Questions

The global ELISA analyzers market size was reached at USD 667.58 million in 2022 and it is projected to hit around USD 871.38 million by 2032.

The global ELISA analyzers market is growing at a compound annual growth rate (CAGR) of 2.7% from 2023 to 2032.

Key factors that are driving the ELISA analyzers market growth include rising need for solutions to reduce healthcare costs, increasing focus on patient-centric care, and strong government support.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on ELISA Analyzers Market 

5.1. COVID-19 Landscape: ELISA Analyzers Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global ELISA Analyzers Market, By Type

8.1. ELISA Analyzers Market, by Type, 2023-2032

8.1.1. Optical Filter Elisa Analyzer

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Optical Grating ELISA Analyzers

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global ELISA Analyzers Market, By Mode

9.1. ELISA Analyzers Market, by Mode, 2023-2032

9.1.1. Automated ELISA Analyzers

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Semi-Automated Analyzers

9.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global ELISA Analyzers Market, By Application 

10.1. ELISA Analyzers Market, by Application, 2023-2032

10.1.1. Immunology

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Vaccine development

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Drug Monitoring

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global ELISA Analyzers Market, By End-user 

11.1. ELISA Analyzers Market, by End-user, 2023-2032

11.1.1. Biotechnology Companies

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Pharmaceutical Companies

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Contract Research Organization

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Diagnostic Laboratories

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global ELISA Analyzers Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.2. Market Revenue and Forecast, by Mode (2020-2032)

12.1.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.4. Market Revenue and Forecast, by End-user (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Mode (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Mode (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.2. Market Revenue and Forecast, by Mode (2020-2032)

12.2.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Mode (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Mode (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Mode (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Mode (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.2. Market Revenue and Forecast, by Mode (2020-2032)

12.3.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Mode (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Mode (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Mode (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Mode (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.2. Market Revenue and Forecast, by Mode (2020-2032)

12.4.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Mode (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Mode (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Mode (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Mode (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-user (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.2. Market Revenue and Forecast, by Mode (2020-2032)

12.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Mode (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Mode (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-user (2020-2032)

Chapter 13. Company Profiles

13.1. Thermo Fisher Scientific

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Abcam

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Bio-Rad Laboratories

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Merck KGaA

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. F. Hoffmann-La Roche Ltd

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Danaher Corporation

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. BioTech

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Agilent Technologies

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. QIAGEN

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. PerkinElmer Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers